$ETNB
89bio, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023040702 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.930M $7.214M $5.052M
YoY Change 63.71% 42.79% 2.66%
% of Gross Profit
Research & Development $31.42M $34.92M $19.69M
YoY Change 41.54% 77.36% 25.95%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $16.00K
YoY Change -37.5% -37.5% 6.67%
% of Gross Profit
Operating Expenses $39.35M $42.13M $24.74M
YoY Change 45.5% 70.3% 20.37%
Operating Profit -$39.35M -$42.13M -$24.74M
YoY Change 45.5% 70.3% 20.37%
Interest Expense $959.0K $894.0K $434.0K
YoY Change 79.25% 105.99% -208.5%
% of Operating Profit
Other Income/Expense, Net $5.579M $4.630M -$316.0K
YoY Change 2244.12% -1565.19% 83.72%
Pretax Income -$34.73M -$38.39M -$25.05M
YoY Change 29.56% 53.24% 20.9%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$34.73M -$38.39M -$25.05M
YoY Change 29.55% 53.24% 20.9%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$0.52 -$1.23
Diluted Earnings Per Share -$0.45 -$0.52 -$1.23
COMMON SHARES
Basic Shares Outstanding 75.48M 72.87M 20.35M
Diluted Shares Outstanding 76.34M 74.13M 20.35M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $448.3M $478.0M $139.3M
YoY Change 131.87% 243.08% -18.51%
Cash & Equivalents $251.9M $245.4M $60.62M
Short-Term Investments $196.4M $232.6M $78.71M
Other Short-Term Assets $11.20M $13.88M $7.243M
YoY Change 71.96% 91.62% -24.63%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $459.5M $491.9M $146.6M
YoY Change 129.93% 235.59% -18.83%
LONG-TERM ASSETS
Property, Plant & Equipment $58.00K $68.00K $121.0K
YoY Change -44.76% -43.8% -21.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $289.0K $289.0K $797.0K
YoY Change 32.57% -63.74% -19.0%
Total Long-Term Assets $585.0K $637.0K $1.027M
YoY Change -19.42% -37.97% -9.75%
TOTAL ASSETS
Total Short-Term Assets $459.5M $491.9M $146.6M
Total Long-Term Assets $585.0K $637.0K $1.027M
Total Assets $460.1M $492.5M $147.6M
YoY Change 129.39% 233.69% -18.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.90M $10.72M $4.907M
YoY Change -22.95% 118.36% 156.24%
Accrued Expenses $14.13M $15.06M $14.39M
YoY Change 5.18% 4.64% 153.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.500M
YoY Change
Total Short-Term Liabilities $25.21M $25.94M $26.90M
YoY Change -26.76% -3.55% 254.87%
LONG-TERM LIABILITIES
Long-Term Debt $24.64M $24.48M $12.05M
YoY Change 90.13% 103.18% 745.02%
Other Long-Term Liabilities $100.0K $98.00K $28.46M
YoY Change -83.97% -99.66%
Total Long-Term Liabilities $24.64M $24.48M $12.05M
YoY Change 90.13% 103.18% 745.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.21M $25.94M $26.90M
Total Long-Term Liabilities $24.64M $24.48M $12.05M
Total Liabilities $49.90M $50.53M $67.41M
YoY Change 3.95% -25.05% 648.5%
SHAREHOLDERS EQUITY
Retained Earnings -$417.2M -$382.5M -$263.8M
YoY Change 43.54% 44.97%
Common Stock $828.0M $825.1M $344.3M
YoY Change 86.62% 139.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $410.2M $442.0M $80.19M
YoY Change
Total Liabilities & Shareholders Equity $460.1M $492.5M $147.6M
YoY Change 129.39% 233.69% -18.77%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$34.73M -$38.39M -$25.05M
YoY Change 29.55% 53.24% 20.9%
Depreciation, Depletion And Amortization $10.00K $10.00K $16.00K
YoY Change -37.5% -37.5% 6.67%
Cash From Operating Activities -$30.36M -$34.45M -$14.84M
YoY Change 104.93% 132.2% -26.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $1.000K
YoY Change -100.0% -105.0%
Acquisitions
YoY Change
Other Investing Activities $38.32M -$101.8M -$7.597M
YoY Change -191.11% 1240.11% -45.17%
Cash From Investing Activities $38.32M -$101.8M -$7.596M
YoY Change -191.11% 1240.28% -45.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.480M 30.77M 28.16M
YoY Change -102.16% 9.25% 1568.25%
NET CHANGE
Cash From Operating Activities -30.36M -34.45M -14.84M
Cash From Investing Activities 38.32M -101.8M -7.596M
Cash From Financing Activities -1.480M 30.77M 28.16M
Net Change In Cash 6.480M -105.5M 5.729M
YoY Change -44.89% -1941.32% -117.74%
FREE CASH FLOW
Cash From Operating Activities -$30.36M -$34.45M -$14.84M
Capital Expenditures $0.00 $0.00 $1.000K
Free Cash Flow -$30.36M -$34.45M -$14.84M
YoY Change 104.93% 132.19% -26.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001785173
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39122
dei Entity Registrant Name
EntityRegistrantName
89bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4946844
dei Entity Address Address Line1
EntityAddressAddressLine1
142 Sansome Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Second Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
432-9270
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ETNB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19686000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57221000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39535000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7214000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5052000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13432000
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75480884
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245441000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55255000
CY2023Q2 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
232554000
CY2022Q4 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
132905000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13879000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7920000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
491874000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
196080000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
280000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
363000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
289000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
289000
CY2023Q2 us-gaap Assets
Assets
492511000
CY2022Q4 us-gaap Assets
Assets
196824000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10715000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12502000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15056000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11944000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
173000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
168000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
25944000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24614000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
186000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24483000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20192000
CY2023Q2 us-gaap Liabilities
Liabilities
50525000
CY2022Q4 us-gaap Liabilities
Liabilities
44992000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
51000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
824977000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467374000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-594000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-350000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-382472000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-315243000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
441986000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
151832000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
492511000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
196824000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34915000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.06
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10311000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
42129000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
24738000
us-gaap Operating Expenses
OperatingExpenses
70653000
us-gaap Operating Expenses
OperatingExpenses
49846000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-42129000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24738000
us-gaap Operating Income Loss
OperatingIncomeLoss
-70653000
us-gaap Operating Income Loss
OperatingIncomeLoss
-49846000
CY2023Q2 us-gaap Interest Expense
InterestExpense
894000
CY2022Q2 us-gaap Interest Expense
InterestExpense
434000
us-gaap Interest Expense
InterestExpense
2969000
us-gaap Interest Expense
InterestExpense
842000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4630000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6393000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38393000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25054000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67229000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50618000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38393000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-25054000
us-gaap Net Income Loss
NetIncomeLoss
-67229000
us-gaap Net Income Loss
NetIncomeLoss
-50619000
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-355000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-77000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-241000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-272000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-354000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-244000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-254000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38747000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25116000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-67473000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50873000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.49
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74126569
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74126569
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20351560
us-gaap Depreciation
Depreciation
34000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5816000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4037000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20351560
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63706856
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63706856
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20345521
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20345521
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
151832000
CY2023Q1 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
8960000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
185000
CY2023Q1 etnb Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
-693000
CY2023Q1 etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
482000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3551000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28836000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
110000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
445830000
CY2023Q2 etnb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
6630000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
327000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
142000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4137000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38393000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-354000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
441986000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125957000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2512000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25565000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-192000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
102741000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-69000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2586000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-25054000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80185000
us-gaap Profit Loss
ProfitLoss
-67229000
us-gaap Profit Loss
ProfitLoss
-50619000
us-gaap Share Based Compensation
ShareBasedCompensation
7688000
us-gaap Share Based Compensation
ShareBasedCompensation
5098000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2188000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-128000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
185000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
245000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
271000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
152000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1208000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
83000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
91000
us-gaap Depreciation
Depreciation
24000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
507000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1787000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1936000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3112000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4194000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-83000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-96000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64532000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39179000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
82880000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
59912000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
180582000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
40731000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97702000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19176000
etnb Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
296817000
etnb Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
28186000
etnb Proceeds From Issuance Public Offering At The Market Offering
ProceedsFromIssuancePublicOfferingAtTheMarketOffering
37089000
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
24363000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
15590000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
512000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
29000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
142000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
693000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
69000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
21400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
352420000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28189000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
190186000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8186000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55255000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52457000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245441000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60643000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245441000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60618000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245441000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60643000
us-gaap Interest Paid Net
InterestPaidNet
1198000
us-gaap Interest Paid Net
InterestPaidNet
404000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
93000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
127000
etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
482000
etnb Offering Costs Included In Other Assets And Accrued Expenses
OfferingCostsIncludedInOtherAssetsAndAccruedExpenses
580000
CY2022Q4 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
6499000
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
478000000.0
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior period amounts in the Company’s condensed consolidated statements of operations and comprehensive loss have been reclassified to conform to the current period presentation. Specifically, interest expense is disclosed separately on the Company’s condensed consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates </span><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include but are not limited to accrued research and development expenses, the fair value of stock options and unrecognized tax benefits. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits increased by approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the three and six months ended June 30, 2023. This change had no impact on the effective tax rate because of corresponding deductions from deferred tax assets.</span></p>
CY2023Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
6700000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
6700000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
333305000
CY2023Q2 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
25259000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
358564000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
175243000
CY2022Q4 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
6202000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
181445000
CY2023Q2 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
11519000
CY2022Q4 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
5727000
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
608000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
646000
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1752000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1547000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13879000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7920000
CY2023Q2 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
11023000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2760000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4165000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1191000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1052000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
82000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
228000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15056000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11944000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10789000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13024000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1187000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000000
CY2023Q2 us-gaap Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
185000
CY2023Q2 etnb Debt Instrument Carrying Amount Including Periodic Payment Terms Balloon Payment To Be Paid
DebtInstrumentCarryingAmountIncludingPeriodicPaymentTermsBalloonPaymentToBePaid
25185000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
702000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24483000
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14508511
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11243527
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.916
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.982
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.038
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.028
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4137000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2586000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7688000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5098000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16677533
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3811845

Files In Submission

Name View Source Status
0000950170-23-040702-index-headers.html Edgar Link pending
0000950170-23-040702-index.html Edgar Link pending
0000950170-23-040702.txt Edgar Link pending
0000950170-23-040702-xbrl.zip Edgar Link pending
etnb-20230630.htm Edgar Link pending
etnb-20230630.xsd Edgar Link pending
etnb-ex31_1.htm Edgar Link pending
etnb-ex31_2.htm Edgar Link pending
etnb-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
etnb-20230630_cal.xml Edgar Link unprocessable
etnb-20230630_lab.xml Edgar Link unprocessable
etnb-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
etnb-20230630_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etnb-20230630_def.xml Edgar Link unprocessable